Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04613557
Title Safety, Activity and Cell Kinetics of CYAD-211 in Patients With Relapsed or Refractory Multiple Myeloma (IMMUNICY-1)
Acronym IMMUNICY-1
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Celyad Oncology SA
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | BEL

Facility Status City State Zip Country Details
H. Lee Moffitt Cancer Center Tampa Florida 33612 United States Details
Nyu Langone Hospitals New York New York 10016 United States Details
Universitair Ziekenhuis Antwerpen Antwerp 2650 Belgium Details
Institut Jules Bordet Brussels 1000 Belgium Details
AZ DELTA Roeselare 8800 Belgium Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field